Subsequent gene expression analyses have shown that human Rab45/RASEF is detected in many cancer cells, such as myeloid leukemia [47], uveal malignant melanoma [48], colorectal cancer [49], lung cancer [50], and breast cancer [51,52,53]. Here, RASEF is linked to breast carcinoma.